Thyroid function tests are frequently ordered test. Infrequently, the automated thyroid hormone assay system is subjected to interference which may yield false results, thus leading to inappropriate diagnosis and management. We report an unusual case of clinically misdiagnosed subclinical hyperthyroidism with undetectable TSH due to negative interference in particular TSH assay platforms in a young Nepalese male.
Introduction
Thyroid function test is offered as a routine investigation by most of the clinical laboratories. Clinical and biochemical phenotype correlation is required for the correct interpretation of thyroid hormone test result. Measurement of thyroid hormones in serum by immunoassay method is preferred and has also been advocated since many years. 1 Susceptibility of automated thyroid hormone immunoassays to interference leads to false result, with the potential for inappropriate diagnosis and management. There are many cases, where discordant thyroid stimulating hormone (TSH) measurement in euthyroid subjects is reported. The common causes of interference in thyroid hormone measurement are intake of biotin containing multivitamins by patient and presence of heterophile antibodies, rheumatoid factor or paraprotein in patient's serum. 2, 3, 4 It should be noted that high affinity of the noncovalent biotinstreptavidin interaction has been extensively used in competitive immunoassays. Thus, additional immunoassay interference that should be taken into consideration in discordant thyroid hormone measurement is antistreptavidin antibodies, anti-ruthenium antibodies and thyroid hormone autoantibodies. 5 Thyroid hormone immunoassay is based on antibody targeted against two different region of TSH dimer. Whenever the immunogenicity of patients TSH is altered due to change in peptide sequence of TSH, then some immunoassays cannot detect this TSH although the biological function of TSH is retained. This normal TSH variant leads to misdiagnosis of subclinical hyperthyroidism in the absence of clinical symptoms. Here we present a case of 25 years male, who is a medical student and was misdiagnosed with subclinical hyperthyroidism possibly due to TSH variant.
Case Report
A 25 years old male ordered his thyroid function test (TFT) as a routine checkup along with other tests at one of the private laboratory in Kathmandu. He had no past illness and was completely normal while performing test. He had normal serum free triiodothyronine (T3) and free thyroxine (T4) level but TSH 3rd generation was less than 0.01. He repeated his test after two weeks at same laboratory and the TFT findings were same. He went for endocrinology consultation where he was diagnosed with subclinical hyperthyroidism. He was advised to perform additional test like anti thyroid peroxidase antibody (TPO antibody) and antithyroglobulin. He was also advised to start treatment. He crosschecked his TFT few days later before starting treatment at next private laboratory in Kathmandu. This time his serum fT3, fT4 and TSH were in normal range. He came to our laboratory for counseling. He had no viral illness and neck pain during the past 3 months. He was not taking multivitamins or levothyroxine and had no major illness. At this time his reports for anti TPO and antithyroglobulin were available which were negative. We repeated the thyroid function test at our laboratory and again the serum TSH level was less than 0.01. We contacted the laboratories where he had done his tests. In the first laboratory where TSH was undetected, they were using Siemens Advia Centaur XP immunoassay.
The second laboratory where the TFT test was normal, were using Roche immunoassay system. At our laboratory we are using both Siemens and Abott Architect immunoassay. We discussed with the patient and repeated the test in Abbott TSH immunoassay system, where the results were normal. The patient was then explained about the TSH variant and was reassured that he does not need treatment for this condition.
Discussion
TSH is routinely measured in the clinical laboratory to diagnose and monitor thyroid disorders. Thirdgeneration serum TSH assays have the highest sensitivity for assessing thyroid disorders. 6 Immunoassay system is currently the method of choice in clinical laboratories for the measurement of thyroid hormones. However, immunoassays are vulnerable to different types of interference that can result in discordant result of thyroid function test. This arginine-55 is part of an epitope recognised by antibodies used in some immunoassays, explaining loss of TSH immunoreactivity in such platforms. In our patient TSH determined by Siemens assay was undetectable but his serum TSH was found to be normal when determined by Roche and Abbot Immunoassay system. Thus, testing the serum with different auto analyzer should be considered when erroneous TSH result is suspected. We could not perform TSH beta region gene sequencing due to financial constraint. It was easier to counsel our patient since he was a medical student.
Conclusion
Physicians practicing endocrinology need to be aware about basic principle of immunoassay and types of interferences. In addition, collaboration between physician and laboratory personnel is needed to minimize the potential for inappropriate treatment. The high frequency of TSH-beta region mutation in our population mandates that, undetectable TSH readings in euthyroid patients should be reanalyzed using an alternate TSH assay.
